Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study

作者：Shankar Siva, David Pryor, Jarad M. Martin, Nicholas Hardcastle, Daniel Moon, Tomas Kron, Braden Higgs, Farshad Foroudi, Jeremy Ruben, Swetha Sridharan, Rebecca Montgomery, Ryan Davey, Charles Lin, Mark Shaw, Nathan Lawrentschuk, Sree Appu, Ben G. L. Vanneste, Michael S. Hofman, Declan G. Murphy, Richard De Abreu Lourenco, Pascal Mancuso, Nicholas R. Brook, Avi Raman, Lih‐Ming Wong, Mark Sidhom, Simon Wood, Muhammad Ali, Mathias Bressel · 发表于：The Lancet Oncology · 年份：2026 · DOI：10.1016/s1470-2045(26)00091-4 · 被引用次数：5 · 研究领域：Renal cell carcinoma treatment、Hepatocellular Carcinoma Treatment and Prognosis、Prostate Cancer Diagnosis and Treatment